Month: <span>September 2022</span>

Home / 2022 / September
What do aged care residents do all day? We tracked their time use to find out
Post

What do aged care residents do all day? We tracked their time use to find out

by Joyce Siette and Laura Dodds, The Conversation Credit: cottonbro/Pexels, CC BY What’s the daily routine like for older people in residential aged care facilities? To find out, we spent 312 hours observing 39 residents at six Australian aged care facilities to learn how and where they spend their time across the day. We wanted to know how socially engaged...

Some viruses that cause cancer suppress the immune system with help from common bacteria
Post

Some viruses that cause cancer suppress the immune system with help from common bacteria

by University of Chicago Credit: Unsplash/CC0 Public Domain Gut bacteria have a profound impact on health by aiding digestion, providing nutrients and metabolites, and working with the immune system to fend off pathogens. Some gut bacteria, however, have been implicated in progression of cancers of the gut and associated organs. A new study by researchers...

Review sheds light on protein drug target for treating non-alcoholic fatty liver disease
Post

Review sheds light on protein drug target for treating non-alcoholic fatty liver disease

by Cactus Communications  A new CMJ article explores the possibility of using the transport protein Retinol-binding protein-4 as a therapeutic target to treat NAFLD. Credit: Albaraa Mehdar It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related...

Honey may find use in eradicating life-threatening lung infections
Post

Honey may find use in eradicating life-threatening lung infections

By Ben Coxworth September 12, 2022 Manuka honey is produced in Australia and New Zealand by bees that pollinate the tea tree shrub Depositphotos People with cystic fibrosis are vulnerable to potentially fatal Mycobacterium abscessus lung infections, which are notoriously difficult to treat. A new treatment may succeed where others have failed, however – and it utilizes...

Immune cells engineered to battle cancer can be turned ‘on’ or ‘off’
Post

Immune cells engineered to battle cancer can be turned ‘on’ or ‘off’

by  Boston University Credit: CC0 Public Domain The billions of immune cells that help protect us from diseases do amazing things, but sometimes they need a little boost. For decades, scientists have been trying to figure out ways to engineer living immune cells to better combat aggressive diseases, like cancer. One big, relatively recent advancement in...

Post

Blood Test for Multiple Cancers: Many False Positives

Roxanne Nelson, RN, BSN September 11, 2022 Dr Deborah Schrag PARIS — New results from a large prospective trial give a better idea of how a blood test that can detect multiple cancers performs in a “real-life” setting. “As this technology develops, people must continue with their standard cancer screening, but this is a glimpse...

New therapeutic target against the most common lung cancer
Post

New therapeutic target against the most common lung cancer

UNIVERSITY OF BARCELONA IMAGE: FROM LEFT TO RIGHT: MARSELINA ARSHAKYAN, ELBA MARÍN (FRONT), PAULA DUCH, CRISTINA TEIXIDÓ, NOEMÍ REGUART, RAFAEL IKEMORI, JORDI ALCARAZ, MARTA GABASA AND NATALIA DÍAZ. CREDIT: UNIVERSITY OF BARCELONA The TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role...

Eating Peanuts May Help With Weight Loss, Blood Pressure, and Glucose
Post

Eating Peanuts May Help With Weight Loss, Blood Pressure, and Glucose

BY QUINN PHILLIPS | SEPTEMBER 9, 2022 Regular consumption of peanuts before meals may help support metabolic health — in the areas of body weight, blood pressure, and blood glucose — according to a new study published in the journal Nutrients. Peanuts aren’t widely thought of as a health food, but there is evidence that they may be compatible with...

DyAnsys Neurostimulation Device Approved for Neuropathic Pain
Post

DyAnsys Neurostimulation Device Approved for Neuropathic Pain

BY QUINN PHILLIPS | AUGUST 2, 2022 The U.S. Food and Drug Administration (FDA) has approved a neurostimulation device from DyAnsys, Inc., to treat pain related to diabetic peripheral neuropathy, according to a press release from the company. The newly approved device, called First Relief, is what’s known as a PENS (percutaneous electrical neurostimulation) device. That means...